Breast Lump

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 7065 Experts worldwide ranked by ideXlab platform

Nita Khurana - One of the best experts on this subject based on the ideXlab platform.

Shramana Mandal - One of the best experts on this subject based on the ideXlab platform.

Eleanor Cornford - One of the best experts on this subject based on the ideXlab platform.

A Masters - One of the best experts on this subject based on the ideXlab platform.

H C Burrell - One of the best experts on this subject based on the ideXlab platform.

  • role of targeted reassurance Breast ultrasound in women with symptoms of a Breast Lump and normal clinical examination
    Breast Cancer Research, 2012
    Co-Authors: R Gallagher, H C Burrell, Eleanor Cornford
    Abstract:

    Ultrasound has a well-established role in the triple assessment of Breast Lumps. The purpose of this study was to review the value of targeted Breast ultrasound in women presenting with symptoms of a Breast Lump but normal clinical examination.

  • woman feels Breast Lump surgeon cannot the role of ultrasound in arbitration
    European Journal of Cancer, 2004
    Co-Authors: R S Rampaul, Ian O Ellis, A R M Wilson, H C Burrell, Andrew Evans, R W Blamey, R D Macmillan
    Abstract:

    Abstract The role of ultrasound scanning (USS) in patients complaining of a Breast Lump where the clinical examination (CE) is normal is not clearly defined. To determine this in greater detail, all patients complaining of a Breast Lump underwent CE. Where no Lump could be found, but was still reported by the patient, an USS was performed. All lesions underwent biopsy and/or aspiration, as well as mammography in suspicious cases or those over 40 years of age. This cohort represented 5% of all referrals in the study period. Four hundred and twenty women were prospectively studied in this way. Median follow up is 3.4 years (range 2.5–4.2 years). Twenty two had solid Lumps (of which 3 were cancers) and 48 had cysts. Ninteen patients re-presented with symptoms in the same Breast (median time=12 months (range 4.5–20 months), all of which were imaged on USS: 15 cysts and 4 further cancers (3 in the same quadrant as the original Lump, one contralateral) were identified. Women with symptomatic Breast Lumps and a normal CE can be considered a reliable indication that cancer is very unlikely to be present (negative predictive value=0.98). Ultrasound may be a suitable complimentary investigation, which will relieve symptoms in those with cysts and can detect small clinically – and sometimes mammographically – occult Breast cancers.